![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 413/12 |
(11) | Number of the document | 2545048 |
(13) | Kind of document | T |
(96) | European patent application number | 11714473.3 |
Date of filing the European patent application | 2011-04-01 | |
(97) | Date of publication of the European application | 2013-01-16 |
(45) | Date of publication and mention of the grant of the patent | 2014-10-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/030892 |
Date | 2011-04-01 |
(87) | Number | WO 2011/123754 |
Date | 2011-10-06 |
(30) | Number | Date | Country code |
392770 P | 2010-10-13 | US | |
392759 P | 2010-10-13 | US | |
417632 P | 2010-11-29 | US | |
329284 P | 2010-04-29 | US | |
320062 P | 2010-04-01 | US | |
353398 P | 2010-06-10 | US | |
326922 P | 2010-04-22 | US |
(72) |
KWOKAL, Ana, HR
HEDVATI, Lilach, IL
BURSTEIN, Revital, IL
YEORI, Adi, IL
MOSHKOVITS-KAPTSAN, Rinat, IL
|
(73) |
Teva Pharmaceutical Industries Ltd.,
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva,
IL
|
(54) | RALTEGRAVIR SALTS AND CRYSTALLINE FORMS THEREOF |
RALTEGRAVIR SALTS AND CRYSTALLINE FORMS THEREOF |